These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2299300

  • 21. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
    Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
    [Abstract] [Full Text] [Related]

  • 22. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK, Cheng IK.
    Postgrad Med J; 1987 Sep; 63(743):757-9. PubMed ID: 3444800
    [Abstract] [Full Text] [Related]

  • 23. [Effect of probucol on the blood concentration of cyclosporin A in patients with nephrotic syndrome: a case study with a microemulsion formulation (Neoral)].
    Wakasugi H, Yoshimoto M, Ono T, Muso E, Inui K.
    Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):792-7. PubMed ID: 12607968
    [Abstract] [Full Text] [Related]

  • 24. Analysis of side-effects of medium- and low-dose cyclosporin maintenance therapy in psoriasis.
    de Rie MA, Meinardi MM, Bos JD.
    Br J Dermatol; 1990 Sep; 123(3):347-53. PubMed ID: 2206973
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
    Turk J Pediatr; 1999 Sep; 41(2):225-30. PubMed ID: 10770662
    [Abstract] [Full Text] [Related]

  • 26. [Effect of probucol on the concentration of cyclosporin A in patients with nephrotic syndrome].
    Wakasugi H, Yoshimoto M, Aoki M, Osawa R, Futami T, Ono T, Muso E, Inui K.
    Nihon Jinzo Gakkai Shi; 2001 Oct; 43(7):595-9. PubMed ID: 11725557
    [Abstract] [Full Text] [Related]

  • 27. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression.
    Ulinski T, Perrin L, Guigonis V, Driss F, Deschênes G, Bensman A.
    Pediatr Nephrol; 2007 Oct; 22(10):1723-6. PubMed ID: 17636340
    [Abstract] [Full Text] [Related]

  • 28. [Effects of cyclosporin A on the diurnal variation of blood pressure in patients with nephrotic syndrome].
    Takakuwa H, Yokoyama H, Yamamoto Y, Takasawa K, Ise T, Kobayashi K, Kawabata M, Takabatake T, Ohta H.
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):400-7. PubMed ID: 9198362
    [Abstract] [Full Text] [Related]

  • 29. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 30. Evaluation and management of steroid-unresponsive nephrotic syndrome.
    Del Rio M, Kaskel F.
    Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
    [Abstract] [Full Text] [Related]

  • 31. [Steroid-free treatment of renal transplant patients with cyclosporin A. A European multicentre study].
    Beveridge T, Maurer W, Poole TW, Wood AJ, Wiskott E.
    Klin Wochenschr; 1982 Sep 15; 60(18):1137-42. PubMed ID: 6755046
    [Abstract] [Full Text] [Related]

  • 32. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
    Nephrol Dial Transplant; 2005 Oct 15; 20(10):2243-7. PubMed ID: 16030039
    [Abstract] [Full Text] [Related]

  • 33. Serum creatinine in cyclosporin-induced remission of steroid-resistant nephrotic syndrome.
    Miller C, Feutren G, Schiess W, von Graffenried B.
    Lancet; 1990 Jun 02; 335(8701):1352. PubMed ID: 1971415
    [No Abstract] [Full Text] [Related]

  • 34. Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome.
    Borel JF.
    Clin Nephrol; 1991 Jun 02; 35 Suppl 1():S23-30. PubMed ID: 1860262
    [Abstract] [Full Text] [Related]

  • 35. Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience.
    Capodicasa G, De Santo NG, Nuzzi F, Giordano C.
    Int J Pediatr Nephrol; 1986 Jun 02; 7(2):69-72. PubMed ID: 3522457
    [Abstract] [Full Text] [Related]

  • 36. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
    Clasen W, Kindler J, Mihatsch MJ, Sieberth HG.
    Nephrol Dial Transplant; 1988 Jun 02; 3(6):733-7. PubMed ID: 3147414
    [Abstract] [Full Text] [Related]

  • 37. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases.
    Br J Dermatol; 1990 Jun 02; 122 Suppl 36():95-100. PubMed ID: 2369573
    [Abstract] [Full Text] [Related]

  • 38. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A.
    Takashima A, Morita A, Tsuji T.
    J Dermatol; 1990 Aug 02; 17(8):482-8. PubMed ID: 2229652
    [Abstract] [Full Text] [Related]

  • 39. Dosage of Cyclosporin A in children with renal transplants.
    Hoyer PF, Offner G, Wonigeit K, Brodehl J, Pichlmayr R.
    Clin Nephrol; 1984 Aug 02; 22(2):68-71. PubMed ID: 6383673
    [Abstract] [Full Text] [Related]

  • 40. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov 02; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.